000132653 001__ 132653
000132653 005__ 20240228140959.0
000132653 0247_ $$2doi$$a10.1186/s12885-015-2006-2
000132653 0247_ $$2pmid$$apmid:26686362
000132653 0247_ $$2pmc$$apmc:PMC4684916
000132653 0247_ $$2altmetric$$aaltmetric:4901167
000132653 037__ $$aDKFZ-2018-00313
000132653 041__ $$aeng
000132653 082__ $$a610
000132653 1001_ $$aSafi, Seyer$$b0
000132653 245__ $$aA randomized phase II study of radiation induced immune boost in operable non-small cell lung cancer (RadImmune trial).
000132653 260__ $$aLondon$$bBioMed Central$$c2015
000132653 3367_ $$2DRIVER$$aarticle
000132653 3367_ $$2DataCite$$aOutput Types/Journal article
000132653 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1522849229_24876
000132653 3367_ $$2BibTeX$$aARTICLE
000132653 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000132653 3367_ $$00$$2EndNote$$aJournal Article
000132653 520__ $$aLung cancer is the leading cause of cancer deaths worldwide. Surgery, radiotherapy at conventional and high dose and chemotherapy are the mainstay for lung cancer treatment. Insufficient migration and activation of tumour specific effector T cells seem to be important reasons for inadequate host anti-tumour immune response. Ionizing radiation can induce a variety of immune responses. The goal of this randomized trial is to assess if a preoperative single fraction low dose radiation is able to improve anti-tumour immune response in operable early stage lung cancer.This trial has been designed as an investigator-initiated, prospective, randomized, 2-armed phase II trial. Patients who are candidates for elective resection of early stage non-small cell lung cancer will be randomized into 2 arms. A total of 36 patients will be enrolled. The patients receive either 2 Gy or no radiation prescribed to their primary tumour. Radiation will be delivered by external beam radiotherapy using 3D radiotherapy or intensity-modulated radiation technique (IMRT) 7 days prior to surgical resection. The primary objective is to compare CD8+ T cell counts detected by immunohistochemistry in resected tumours following preoperative radiotherapy versus no radiotherapy. Secondary objectives include the association between CD8+ T cell counts and progression free survival, the correlation of CD8+ T cell counts quantified by immunohistochemistry and flow cytometry, local tumour control and recurrence patterns, survival, radiogenic treatment toxicity and postoperative morbidity and mortality. Further, frequencies of tumour reactive T cells in blood and bone marrow as well as whole blood cell transcriptomics and plasma-proteomics will be correlated with clinical outcome.This unique intervention combining preoperative low dose radiation and surgical removal of early stage non-small cell lung cancer is designed to address the problem of inadequate host anti-tumour immune response. If successful, this study may affect the role of radiotherapy in lung cancer treatment.NCT02319408;December 29, 2014.
000132653 536__ $$0G:(DE-HGF)POF3-315$$a315 - Imaging and radiooncology (POF3-315)$$cPOF3-315$$fPOF III$$x0
000132653 588__ $$aDataset connected to CrossRef, PubMed,
000132653 7001_ $$0P:(DE-He78)1732377f6242a18280bc6aaa196988d1$$aBeckhove, Philipp$$b1$$udkfz
000132653 7001_ $$aWarth, Arne$$b2
000132653 7001_ $$0P:(DE-He78)e15dfa1260625c69d6690a197392a994$$aBenner, Axel$$b3$$udkfz
000132653 7001_ $$0P:(DE-HGF)0$$aRoeder, Falk$$b4
000132653 7001_ $$aRieken, Stefan$$b5
000132653 7001_ $$0P:(DE-He78)8714da4e45acfa36ce87c291443a9218$$aDebus, Jürgen$$b6$$udkfz
000132653 7001_ $$aDienemann, Hendrik$$b7
000132653 7001_ $$aHoffmann, Hans$$b8
000132653 7001_ $$0P:(DE-He78)3291aaac20f3d603d96744c1f0890028$$aHuber, Peter$$b9$$eLast author$$udkfz
000132653 773__ $$0PERI:(DE-600)2041352-X$$a10.1186/s12885-015-2006-2$$gVol. 15, no. 1, p. 988$$n1$$p988$$tBMC cancer$$v15$$x1471-2407$$y2015
000132653 909CO $$ooai:inrepo02.dkfz.de:132653$$pVDB
000132653 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)1732377f6242a18280bc6aaa196988d1$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000132653 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)e15dfa1260625c69d6690a197392a994$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000132653 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000132653 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)8714da4e45acfa36ce87c291443a9218$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ
000132653 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)3291aaac20f3d603d96744c1f0890028$$aDeutsches Krebsforschungszentrum$$b9$$kDKFZ
000132653 9131_ $$0G:(DE-HGF)POF3-315$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vImaging and radiooncology$$x0
000132653 9141_ $$y2015
000132653 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bBMC CANCER : 2015
000132653 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000132653 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000132653 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000132653 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal
000132653 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ
000132653 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ
000132653 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000132653 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000132653 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000132653 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000132653 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000132653 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000132653 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000132653 9201_ $$0I:(DE-He78)D015-20160331$$kD015$$lTranslationale Immunologie$$x0
000132653 9201_ $$0I:(DE-He78)C060-20160331$$kC060$$lBiostatistik$$x1
000132653 9201_ $$0I:(DE-He78)E055-20160331$$kE055$$lMolekulare Radioonkologie$$x2
000132653 9201_ $$0I:(DE-He78)E050-20160331$$kE050$$lKKE Strahlentherapie$$x3
000132653 980__ $$ajournal
000132653 980__ $$aVDB
000132653 980__ $$aI:(DE-He78)D015-20160331
000132653 980__ $$aI:(DE-He78)C060-20160331
000132653 980__ $$aI:(DE-He78)E055-20160331
000132653 980__ $$aI:(DE-He78)E050-20160331
000132653 980__ $$aUNRESTRICTED